TICKERNOMICS Sign up
Last Update: 2024-03-28 02:10:39
INDIVIOR PLC ( INDV )
20.57USD
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
INDV
25.81%
SPY
32.74%
INDV
1095.93%
SPY
92.93%
INDV
1614.17%
SPY
224.41%
INDV
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2836.16
3001.16
0.10
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-12.07
2.72
-118.17
-2.68
0.00
-15.01
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-67.53
83.03
-18.67
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
14.4902
-129.33
-107.41
2.74
Other Earnings and Cash Flow Stats:
INDIVIOR PLC ( INDV ) Net Income TTM ($MM) is -233.00
INDIVIOR PLC ( INDV ) Operating Income TTM ($MM) is -317.00
INDIVIOR PLC ( INDV ) Owners' Earnings Annual ($MM) is 0.00
INDIVIOR PLC ( INDV ) Current Price to Owners' Earnings ratio is 0.00
INDIVIOR PLC ( INDV ) EBITDA TTM ($MM) is -292.00
INDIVIOR PLC ( INDV ) EBITDA Margin is -18.67%
Capital Allocation:
INDIVIOR PLC ( INDV ) has paid 0.00 dividends per share and bought back -1.397584 million shares in the past 12 months
INDIVIOR PLC ( INDV ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
INDIVIOR PLC ( INDV ) Interest-bearing Debt ($MM) as of last quarter is 277
INDIVIOR PLC ( INDV ) Annual Working Capital Investments ($MM) are 74
INDIVIOR PLC ( INDV ) Book Value ($MM) as of last quarter is -24
INDIVIOR PLC ( INDV ) Debt/Capital as of last quarter is -1155%
Other Balance Sheet Stats:
INDIVIOR PLC ( INDV ) has 610 million in cash on hand as of last quarter
INDIVIOR PLC ( INDV ) has 1239 million of liabilities due within 12 months, and long term debt 239 as of last quarter
INDIVIOR PLC ( INDV ) has 137 common shares outstanding as of last quarter
INDIVIOR PLC ( INDV ) has 0 million USD of preferred stock value
Academic Scores:
INDIVIOR PLC ( INDV ) Altman Z-Score is 2.00 as of last quarter
INDIVIOR PLC ( INDV ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
INDIVIOR PLC ( INDV ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of INDIVIOR PLC ( INDV ) for the amount of $ on
0.67% of INDIVIOR PLC ( INDV ) is held by insiders, and 68.66% is held by institutions
INDIVIOR PLC ( INDV ) went public on 2014-12-29
Other INDIVIOR PLC ( INDV ) financial metrics:
FCF:-13.00
Unlevered Free Cash Flow:-337.00
EPS:-3.92
Operating Margin:-67.53
Gross Profit Margin:83.03
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:2250.00
Beta:2.74
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About INDIVIOR PLC ( INDV ) :
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based preion drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.